Clinical Research Directory
Browse clinical research sites, groups, and studies.
Phase I Clinical Study of Haplo-HSCT Combined With Hypoxic 3D-Cultured Umbilical Cord MSC for the Treatment of SAA
Sponsor: Chinese PLA General Hospital
Summary
Efficacy and Safety of Sequential Infusion of Hypoxic 3D-Cultured Umbilical Cord Mesenchymal Stem Cells in Haploidentical Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia: A Multicenter, Randomized, Phase 1 Trial
Official title: Efficacy and Safety of Sequential Infusion of Hypoxic 3D-Cultured Umbilical Cord Mesenchymal Stem Cells in Haploidentical Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia: A Multicenter, Randomized, Phase 1 Trial
Key Details
Gender
All
Age Range
6 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2023-08-01
Completion Date
2026-12-31
Last Updated
2026-02-12
Healthy Volunteers
No
Interventions
3D hypoxia-preconditioned UC-MSC group
5 × 10⁵/kg 3D hypoxia-preconditioned UC-MSCs at 4 h before HSC infusion
2D UC-MSC group
5 × 10⁵/kg 2D UC-MSCs at 4 h before HSC infusion
Locations (1)
28 Fuxing Road, Beijing, China.
Beijing, China